187 related articles for article (PubMed ID: 168161)
1. Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.
Rocchi G; Tosato G; Papa G; Ragona G
Int J Cancer; 1975 Aug; 16(2):323-8. PubMed ID: 168161
[TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
3. An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma.
Hilgers F; Hilgers J
Intervirology; 1976; 7(6):309-27. PubMed ID: 67099
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus infections in Brazil. II. Hodgkin's disease.
Evans AS; Carvalho RP; Frost P; Jamra M; Pozzi DH
J Natl Cancer Inst; 1978 Jul; 61(1):19-26. PubMed ID: 209202
[TBL] [Abstract][Full Text] [Related]
5. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
[TBL] [Abstract][Full Text] [Related]
7. The relation between Epstein-Barr virus antibodies and clinical symptomatology and immunodeficiency in patients with Hodgkin's disease.
Mochanko K; Fejes M; Breazavscek DM; Suarez A; Bachmann AE
Cancer; 1979 Dec; 44(6):2065-70. PubMed ID: 228834
[TBL] [Abstract][Full Text] [Related]
8. A population-based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings.
Evans AS; Gutensohn NM
Int J Cancer; 1984 Aug; 34(2):149-57. PubMed ID: 6088401
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
[TBL] [Abstract][Full Text] [Related]
10. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
11. Anti-EBV antibody titers in non-Hodgkin lymphomas.
Dumont J; Liabeuf A; Henle W; Feingold N; Kourilsky FM
Int J Cancer; 1976 Jul; 18(1):14-23. PubMed ID: 181335
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of anti EBV antibodies in non-Hodgkin's lymphomams and angio-immunoblastic lymphadenopathies (author's transl)].
Dumont J; Liabeuf A; Henle W; Ferchal F; Feingold N; Kourilsky FM
Bull Cancer; 1979; 66(4):373-81. PubMed ID: 230873
[TBL] [Abstract][Full Text] [Related]
13. Virus-specific antibodies to Epstein-Barr virus, varicella-zoster virus and rubella virus in renal transplant patients with cytomegalovirus infections.
O'Neill HJ; Shirodaria PV
J Infect; 1992 May; 24(3):301-9. PubMed ID: 1318341
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.
Sakamoto K; Aiba M; Katayama I; Sullivan JL; Humphreys RE; Purtilo DT
Int J Cancer; 1981; 27(4):453-8. PubMed ID: 6268553
[TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease.
Enblad G; Sandvej K; Lennette E; Sundström C; Klein G; Glimelius B; Pallesen G
Int J Cancer; 1997 Jul; 72(3):394-7. PubMed ID: 9247279
[TBL] [Abstract][Full Text] [Related]
16. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6.
Lennette ET; Rymo L; Yadav M; Masucci G; Merk K; Timar L; Klein G
Eur J Cancer; 1993; 29A(11):1584-9. PubMed ID: 8217366
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of Epstein-Barr virus antibody titers and excretion in pediatric patients with Hodgkin's disease.
Lange B; Arbeter A; Hewetson J; Henle W
Int J Cancer; 1978 Nov; 22(5):521-7. PubMed ID: 82539
[TBL] [Abstract][Full Text] [Related]
18. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
Pallesen G; Hamilton-Dutoit SJ; Rowe M; Young LS
Lancet; 1991 Feb; 337(8737):320-2. PubMed ID: 1671232
[TBL] [Abstract][Full Text] [Related]
19. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis.
Larsen PD; Bloomer LC; Bray PF
Neurology; 1985 Mar; 35(3):435-8. PubMed ID: 2983262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
